首页> 外文期刊>Metabolic engineering >Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study: Controllable P(3HB-co-4HB) biosynthesis
【24h】

Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study: Controllable P(3HB-co-4HB) biosynthesis

机译:CRISPRi在涉及多个基因的原核代谢工程中的应用,案例研究:可控制的P(3HB-co-4HB)生物合成

获取原文
获取原文并翻译 | 示例
       

摘要

Clustered regularly interspaced short palindromic repeats interference (CRISPRi) is used to edit eukaiNotic genomes. Here, we show that CRISPRi can also be used for fine-tuning prokaryotic gene expression while simultaneously regulating multiple essential gene expression with less labor and time consumption. As a case study, CRISPRi was used to control polyhydroxyalkanoate (PHA) biosynthesis pathway flux and to adjust PHA composition. A pathway was constructed in Escherichia coil for the production of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] from glucose. The native gene sad encoding E. coli succinate semi-aldehyde dehyclrogenase was expressed under the control of CRISPRi using five specially designed single guide RNAs (sgRNAs) for regulating carbon flux to 4-hyclroxybutyrate (4HB) biosynthesis. The system allowed formation of P(3HB-co-4HB) consisting of 1-9 mol% 4HB. Additionally, succinate, generated by succinyl-coA synthetase and succinate dehydrogenase (respectively encoded by genes sucC, sucD and scihil, sdhB) was channeled preferentially to the 4HB precursor by using selected sgRNAs such as sucC2, sucD2, sclhB2 and sclhAl via CRISPRi. The resulting 4HB content in P(3HB-co-4HB) was found to range from 14 to 18.4 mol% depending on the expression levels of down-regulated genes. The results show that CRISPRi is a feasible method to simultaneously manipulate multiple genes in E. coll. (C) 2015 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.
机译:聚类的规则间隔的短回文重复序列干扰(CRISPRi)用于编辑eukaiNotic基因组。在这里,我们表明CRISPRi还可以用于微调原核基因表达,同时以较少的劳动和时间来调节多个基本基因的表达。作为案例研究,CRISPRi用于控制聚羟基链烷酸酯(PHA)生物合成途径通量并调节PHA组成。在大肠杆菌中构建了一条途径,用于从葡萄糖中产生聚(3-羟基丁酸酯-co-4-羟基丁酸酯)[P(3HB-co-4HB)]。使用五个专门设计的单向导RNA(sgRNA)在CRISPRi的控制下表达了编码大肠杆菌琥珀酸半醛脱氢酶的天然基因sad,用于调节碳通量至4-羟丁酸(4HB)的生物合成。该系统允许形成由1-9mol%的4HB组成的P(3HB-co-4HB)。此外,通过使用选定的sgRNA,例如sucC2,sucD2,sclhB2和sclhB2和sucC2,sucD2,sclhB2和sclhB2和sclhB2和sclhB2和sclhB2和sclhB2和sclhB2和sclhB2和sclhB2和sclhB2和sclhA2,将由琥珀酰辅酶A合成酶和琥珀酸脱氢酶(分别由sucC,sucD和scihil,sdhB基因编码)生成的琥珀酸优先引导至4HB前体。根据下调基因的表达水平,发现P(3HB-co-4HB)中所得的4HB含量范围为14至18.4 mol%。结果表明,CRISPRi是同时操作大肠杆菌中多个基因的可行方法。 (C)2015年国际代谢工程学会。由Elsevier Inc.出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号